PALISADE CAPITAL MANAGEMENT, LP - PARATEK PHARMACEUTICALS INC ownership

PARATEK PHARMACEUTICALS INC's ticker is and the CUSIP is 699374AB0. A total of 3 filers reported holding PARATEK PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 7.4%.

Quarter-by-quarter ownership
PALISADE CAPITAL MANAGEMENT, LP ownership history of PARATEK PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$3,298,019
+20.3%
3,368,000
-2.3%
0.09%
+18.9%
Q1 2023$2,740,365
-9.7%
3,447,0000.0%0.07%
-8.6%
Q4 2022$3,033,360
+7.4%
3,447,000
+8.0%
0.08%
+1.2%
Q3 2022$2,824,000
+3.5%
3,192,0000.0%0.08%
+8.1%
Q2 2022$2,728,000
-3.1%
3,192,0000.0%0.07%
+13.8%
Q1 2022$2,816,000
-3.2%
3,192,0000.0%0.06%
+10.2%
Q4 2021$2,909,000
+2.8%
3,192,0000.0%0.06%
-4.8%
Q3 2021$2,829,000
-10.3%
3,192,000
-5.9%
0.06%
-12.7%
Q2 2021$3,154,000
+1.6%
3,392,000
-1.6%
0.07%
-2.7%
Q1 2021$3,103,000
+4.5%
3,448,0000.0%0.07%
-3.9%
Q4 2020$2,970,000
-7.2%
3,448,000
-10.7%
0.08%
-20.0%
Q3 2020$3,202,000
+0.2%
3,859,000
-2.3%
0.10%
-6.9%
Q2 2020$3,197,000
+20.5%
3,950,000
+5.3%
0.10%
+8.5%
Q1 2020$2,653,000
-1.2%
3,750,0000.0%0.09%
+23.7%
Q4 2019$2,684,000
-1.0%
3,750,0000.0%0.08%
-8.4%
Q3 2019$2,712,000
+2.6%
3,750,0000.0%0.08%
+1.2%
Q2 2019$2,643,0003,750,0000.08%
Other shareholders
PARATEK PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
PenderFund Capital Management Ltd. 20,060,000$22,713,0005.56%
SILVERBACK ASSET MANAGEMENT LLC 7,707,000$6,912,0000.94%
HIGHBRIDGE CAPITAL MANAGEMENT LLC 35,615,000$31,948,0000.74%
DeepCurrents Investment Group LLC 12,521,000$11,079,0000.34%
AGF Investments LLC 4,000,000$3,502,0000.29%
WATER ISLAND CAPITAL LLC 2,250,000$2,014,0000.10%
L & S Advisors Inc 935,000$829,0000.10%
Sculati Wealth Management, LLC 200,000$177,0000.09%
PALISADE CAPITAL MANAGEMENT, LP 3,192,000$2,816,0000.06%
Teton Advisors, Inc. 400,000$354,0000.06%
View complete list of PARATEK PHARMACEUTICALS INC shareholders